CCOC(=O)c1cc(-c2ccc(F)cc2)n(CCC(=O)Nc2nc3ccc(OC)cc3s2)c1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?